Federal Judge Rejects Johnson & Johnson (JNJ) Bankruptcy Strategy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Federal Judge Rejects Johnson & Johnson Bankruptcy Strategy, Paving Way for Talc Victims to Seek Justice in Trial Courts
April 1, 2025 9:29 AM EDTCourt ruling marks major victory for ovarian cancer patients as legal battle shifts to multidistrict litigation
HOUSTON--(BUSINESS WIRE)-- In a resounding victory for thousands of women who have suffered from ovarian cancer linked to Johnson & Johnsons (NYSE: JNJ) talcum powder products, U.S. Bankruptcy Court Judge Christopher Lopez has rejected the companys third attempt to shield itself from liability through bankruptcy.
The ruling clears the way for claimants to seek speedy jury trials in state courts and through the bellwether process in multidistrict litigation... More
